Rifampicin | German Center for Infection Research

Short description

Rifampicin is an antibiotic especially used to treat mycobacterial infections.

Detailed description

Rifampicin inhibits the RNA polymerase – a bacterial enzyme needed for protein production.

Partial view of a dark-skinned man holding different colored pills in the palm of his right hand and a yellow plastic box in his left hand

New clinical standards strengthen antimicrobial stewardship in tuberculosis care

Resistance to antibiotics is increasing worldwide. This also applies to drugs that are central to the treatment of tuberculosis (TB), such as bedaquiline. An international panel of experts from 32

Jan 2025

Lancet Child Adolesc Health

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

Autoren

Garcia-Prats AJ et al.

Jan 2025

Open Forum Infect Dis

Programmatic Diagnostic Accuracy and Clinical Utility of Xpert MTB/XDR in Patients With Rifampicin-Resistant Tuberculosis in Georgia

Autoren

Pfurtscheller T et al.

Feb 2025

Int J Tuberc Lung Dis

Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a community-based intervention

Autoren

Tchakounte Youngui B et al.

Pills dropping from a medicine bottle into the palm of a hand

Open letter: Experts call for urgent expansion of Pretomanid label

A coalition of leading tuberculosis (TB) experts and medical societies—including scientists from the German Center of Infection Research (DZIF)—is calling for an urgent expansion of the European

Aug 2024

Open Forum Infect Dis